- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advocate for Policies and Actions
- Build Rapid-Response Networks
- Improve Research Conduct
- Provide Tools for Decision-Making
- Translate & Share the Latest Information
- Our FocusInterventions to End the Epidemic
- Combination Prevention
- Male and Female Condoms
- Hormonal Contraceptives and HIV
- Multipurpose Prevention Technologies
- HIV Vaccine
- Voluntary Medical Male Circumcision
- How Research Happens
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
The term “microbicide” refers to substances being studied that could be used in the vagina and/or rectum to reduce the risk of HIV infection via sexual exposure. There are no licensed microbicides available today. Vaginal and rectal microbicides could be additional prevention tools for women and men at risk of HIV around the world. Today, daily oral PrEP is the only prevention tool that women can use to reduce risk of HIV that does not require partner negotiation at or around the time of sex. Access to this strategy is limited and expanding slowly. But more options are needed. Simple, easy-to-use vaginal microbicides would fill an important HIV prevention need.
While no microbicide is commercially available, clinical trials could lead to licensing of the first products within this decade. To ensure that people can benefit quickly, the foundation for rollout must be laid now by exploring the feasibility, acceptability and impact of introducing new tools like oral PrEP and developing combination prevention platforms where new products can be easily introduced.
Results from two Phase III multi-country trials (ASPIRE and Ring) studying the 4-week slow-release dapivirine vaginal ring were released at the Conference on Retroviruses and Opportunistic Infection. Click here for press releases, background information and other useful resources about the Ring and ASPIRE studies.
What We're Reading